Radiolabeled Molecules for Medullary Thyroid Cancer
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Radiolabeled Molecules for Medullary Thyroid Cancer, covering 2016-09-07 to 2016-09-07. Get the full timeline:
Most recent: Clinical Trial Update: Radiolabeled Molecules for Medullary Thyroid Cancer [Phase 4]